Mode
Text Size
Log in / Sign up

Palliative care integration reduced diagnostic intensity and costs in adult cancer patients dying at a Jordanian centerPalliative care cuts end-of-life costs and tests for cancer patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that palliative care management reduced diagnostic intensity and costs in this Jordanian cohort.

This retrospective cohort study examined 299 adult cancer patients who died at a tertiary cancer center in Jordan. The analysis categorized patients by the clinical service responsible at death, comparing those managed by oncology versus those managed by palliative care. The primary outcome focused on end-of-life resource utilization and costs during the last seven days of life.

Among the 299 patients, 151 (50.5%) were managed by palliative care at death. Reasons for final admission included decreased level of consciousness in 60 (20.1%) and pain crisis in 57 (19.1%). A total of 1,623 diagnostic exams were performed during the final week. The total cost for these exams was 186,572 USD.

Mean costs and exam numbers were significantly higher in oncology-managed cases. The mean cost of diagnostic exams was 856.58 USD for oncology patients versus 397.38 USD for palliative patients (p < 0.001). The mean number of diagnostic exams was 6.6 for oncology patients versus 4.2 for palliative patients (p < 0.001). Timing of exams occurred earlier in oncology patients (0.39 days from death) compared to palliative patients (2.92 days from death) (p < 0.001). Referral-to-death intervals were 14 days for palliative care referral requests versus 1 day for oncology patients with referral requests (p < 0.001).

Safety data, including adverse events and tolerability, were not reported. Key limitations include the single-center analysis and limited evidence from Middle Eastern cancer centers. Causality was not explicitly claimed, as this is an observational study. Earlier and more consistent integration of palliative care may improve resource utilization and align care with patient-centered goals.

A cancer patient in the final week of life often faces a flood of blood tests, scans, and hospital stays. A new study from Jordan shows a clear way to change that. When palliative care is involved, patients need fewer tests and their families face lower costs.

This matters because cancer is a leading cause of death worldwide. In the last days, patients and families want comfort and dignity. But care can become a cycle of intense testing and hospital visits. That adds stress and expense. It can also pull focus away from what matters most.

For years, many hospitals have treated palliative care as a last resort. It is often called in only when all other options are gone. But here is the twist. This study suggests that palliative care, when started earlier, can reduce the intensity of care at the end of life. It does not mean giving up. It means shifting the focus to comfort and quality of life.

Think of the body like a factory that is running at full speed. In late-stage cancer, the factory is breaking down. More tests and procedures are like adding extra shifts and overtime. It costs more and does not fix the core problem. Palliative care acts like a manager who turns off the lights and locks the doors when the work is done. It helps the body rest. It helps the family plan.

The study looked at 299 adult cancer patients who died at a single tertiary cancer center in Jordan between February 2017 and May 2018. Researchers reviewed who managed their care at death, what tests were done in the last week, and the costs of those tests. They compared patients managed by oncology teams with those managed by palliative care teams.

Patients managed by palliative care had fewer tests and lower costs. In the last seven days of life, the average cost per patient was about 397 dollars for palliative care patients. For oncology patients, it was about 857 dollars. That is more than double. Oncology patients also had more tests, with an average of 6.6 tests per patient compared to 4.2 for palliative care patients. Tests were also done closer to death in oncology patients, often within the last day.

But there is a catch. Referrals to palliative care were often late. Among patients still under oncology care at death, 29 percent had a palliative care referral request. Yet they did not transition to active palliative management. The time from referral request to death was much shorter for these patients. This suggests the system is not using palliative care early enough to make a real difference.

This does not mean palliative care is available everywhere right now.

Experts in the field note that early integration of palliative care can improve both patient outcomes and resource use. The goal is to align care with what patients and families want. That often means more time at home, less time in the hospital, and a focus on comfort.

For patients and families, this study is a reminder to ask about palliative care early. It is not about giving up on treatment. It is about adding a layer of support that can reduce stress and costs. Talk to your oncology team about when palliative care might help. It can be offered alongside cancer treatments.

The study has limits. It looked at one center in Jordan, so results may not apply everywhere. It was also a retrospective review, which means it looked back at past data rather than testing a new treatment. More research is needed to see how these findings translate to other countries and health systems.

What happens next? Researchers hope to see more studies on early palliative care in different settings. Hospitals may use this data to rethink how they refer patients. The goal is to make palliative care a standard part of cancer care, not a last resort.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Evidence from Middle Eastern cancer centers on the impact of palliative care on end-of-life practices remains limited. This study evaluated healthcare utilization, diagnostic costs, and timing of palliative care referral requests at a tertiary cancer center in Jordan. We conducted a retrospective cohort study including all 299 adult cancer patients who died between February 2017 and May 2018. Patients were categorized based on the clinical service responsible at death (oncology vs. palliative care). Demographic and clinical characteristics, reasons for final hospitalization, and costs of laboratory and radiologic exams performed in the last seven days of life were extracted. Descriptive and univariate analyses were performed. Of 299 patients, 151 (50.5%) were managed by palliative care at death. The mean (SD) age was 57.1 ± 14.3 years. The most common reasons for final admission were decreased level of consciousness 60 (20.1%) and pain crisis 57 (19.1%). Among the 148 oncology patients, 43 (29.1%) had documented palliative care referral requests but remained under oncology care at the time death. In the last seven days of life, 1,623 diagnostic exams were performed at a total cost of 186,572 USD. Oncology-managed patients had higher diagnostic intensity and costs compared to palliative patients (mean cost 856.58 vs. 397.38 USD; mean exams 6.6 vs. 4.2; both p < 0.001). Exams were performed closer to death in oncology patients (mean 0.39 vs. 2.92 days; p < 0.001). Referral requests were associated with longer referral-to-death intervals (median 14 vs. 1 day; p < 0.001). Palliative care involvement was associated with lower diagnostic intensity and costs at end of life. However, referral requests were often late or not translated into active palliative management. Earlier and more consistent integration of palliative care may improve resource utilization and align care with patient-centered goals.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.